pentobarbital will reduce the level or influence of bedaquiline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Stay away from coadministration of bedaquiline with sturdy CYP3A4 inducers on account of potential for diminished therapeutic effectpentobarbital will minimize the extent or result of triazolam by